BECTON DICKINSON & CO·4

Mar 18, 10:13 AM ET

Mas Ribo Alberto 4

4 · BECTON DICKINSON & CO · Filed Mar 18, 2019

Insider Transaction Report

Form 4
Period: 2019-03-15
Mas Ribo Alberto
EVP and Pres, Life Sciences
Transactions
  • Disposition to Issuer

    Common Stock

    2019-03-15$255.00/sh1,488$379,44017,586 total
  • Sale

    Common Stock

    2019-03-15$255.00/sh109$27,79515,482 total
  • Exercise/Conversion

    Stock Appreciation Rights

    2019-03-153,4830 total
    Exercise: $108.89From: 2014-11-26Exp: 2023-11-26Common Stock (3,483 underlying)
  • Exercise/Conversion

    Common Stock

    2019-03-15$108.89/sh+3,483$379,26419,074 total
  • Sale

    Common Stock

    2019-03-15$255.00/sh1,995$508,72515,591 total
Holdings
  • Common Stock

    (indirect: By Trust)
    2,554
  • Common Stock

    (indirect: By Trust)
    1,055
Footnotes (3)
  • [F1]Represents shares of common stock held under the Becton, Dickinson and Company Global Share Investment Program (the "GSIP"). The information presented for the GSIP is as of May 31, 2017.
  • [F2]Represents shares of common stock held under the Becton, Dickinson and Company Savings Incentive Plan (the "SIP"). The information presented for the SIP is as of July 31, 2017.
  • [F3]The stock appreciation rights vest in four annual installments beginning November 26, 2014.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT